Entegris Acquires Jetalon Solutions - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Entegris Acquires Jetalon Solutions


Entegris, which supplies contamination-control and materials-handling solutions for demanding manufacturing environments, acquired the assets of privately held Jetalon Solutions, a California-based supplier of fluid metrology products, Entegris reported in a press release.

Jetalon Solutions’ metrology and sensor products use refractive-index technology to achieve greater precision in real-time chemical blending, which is of increasing interest with the trend to continuous manufacturing and real-time monitoring. In biopharmaceutical production, these solutions are used in both upstream and downstream processing. Sensors can be used, for example, in real-time, in-line concentration monitoring of media and buffer preparations.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here